Dynavax Technologies Corp DVAXW:OTCPK

RT Quote | Exchange | USD
Last | 03/01/21 EST
2.74UNCH (UNCH)
52 week range
0.31 - 7.90

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.74
  • 52 Week High7.90
  • 52 Week High Date02/01/21
  • 52 Week Low0.31
  • 52 Week Low Date09/28/20
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Dynavax Technologies Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Its products include HEPLISAV-B, AZD1419, DV281, DV230F and DV1001. HEPLISAV-B is an...
Andrew Hack M.D., Ph.D.
Chairman
Ryan Spencer
Chief Executive Officer
David Novack
President
Michael Ostrach J.D.
Chief Financial Officer
Justin Burgess
Chief Accounting Officer
Address
2100 POWELL STREET, SUITE 900
Emeryville, CA
94608
United States